Novavax Stock Price Prediction
| NVAX Stock | USD 3.97 0.08 2.06% |
Oversold Vs Overbought
41
Oversold | Overbought |
Novavax stock price prediction is an act of determining the future value of Novavax shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Novavax's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Novavax and does not consider all of the tangible or intangible factors available from Novavax's fundamental data. We analyze noise-free headlines and recent hype associated with Novavax, which may create opportunities for some arbitrage if properly timed.
Below are the key fundamental drivers impacting Novavax's stock price prediction:EPS Estimate Next Quarter (0.05) | EPS Estimate Current Year (0.73) | Wall Street Target Price 15.4 | EPS Estimate Current Quarter (0.45) | Quarterly Revenue Growth (0.18) |
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Novavax based on different types of headlines from major news networks to social media. The Novavax stock price prediction module provides an analysis of price elasticity to changes in media outlook on Novavax over a specific investment horizon. Using Novavax hype-based prediction, you can estimate the value of Novavax from the perspective of Novavax response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Novavax using Novavax's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Novavax using crowd psychology based on the activity and movement of Novavax's stock price.
Novavax Short Interest
A significant increase or decrease in Novavax's short interest from the previous month could be a good indicator of investor sentiment towards Novavax. Short interest can provide insight into the potential direction of Novavax stock and how bullish or bearish investors feel about the market overall. An investor who is long Novavax may also wish to track short interest. As short interest increases, investors should be becoming more worried about Novavax and may potentially protect profits, hedge Novavax with its derivative instruments, or be ready for some potential downside.
200 Day MA 6.1236 | Short Percent 0.3657 | Short Ratio 5.45 | Shares Short Prior Month 48.1 M | 50 Day MA 4.6766 |
Novavax Hype to Price Pattern
Investor biases related to Novavax's public news can be used to forecast risks associated with an investment in Novavax. The trend in average sentiment can be used to explain how an investor holding Novavax can time the market purely based on public headlines and social activities around Novavax. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Novavax's market sentiment to its price can help taders to make decisions based on the overall investors consensus about Novavax.
Novavax Implied Volatility | 215.38 |
Novavax's implied volatility exposes the market's sentiment of Novavax stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Novavax's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Novavax stock will not fluctuate a lot when Novavax's options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in Novavax. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Novavax to buy its stock at a price that has no basis in reality. In that case, they are not buying Novavax because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Novavax after-hype prediction price | USD 3.88 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current Novavax contract
Based on the Rule 16, the options market is currently suggesting that Novavax will have an average daily up or down price movement of about 13.46% per day over the life of the 2024-04-19 option contract. With Novavax trading at USD 3.97, that is roughly USD 0.53 . If you think that the market is fully incorporating Novavax's daily price movement you should consider acquiring Novavax options at the current volatility level of 215.38%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Novavax |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Novavax's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Novavax After-Hype Price Prediction Density Analysis
As far as predicting the price of Novavax at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Novavax or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Novavax, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Novavax Estimiated After-Hype Price Volatility
In the context of predicting Novavax's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Novavax's historical news coverage. Novavax's after-hype downside and upside margins for the prediction period are 0.19 and 9.82, respectively. We have considered Novavax's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Novavax is moderately volatile at this time. Analysis and calculation of next after-hype price of Novavax is based on 3 months time horizon.
Novavax Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Novavax is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Novavax backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Novavax, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.06 | 5.94 | 0.01 | 0.03 | 10 Events / Month | 3 Events / Month | In about 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
3.97 | 3.88 | 0.26 |
|
Novavax Hype Timeline
Novavax is now traded for 3.97. The entity has historical hype elasticity of -0.01, and average elasticity to hype of competition of 0.03. Novavax is forecasted to decline in value after the next headline, with the price expected to drop to 3.88. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -0.26%, whereas the daily expected return is now at 0.06%. The volatility of related hype on Novavax is about 1083.94%, with the expected price after the next announcement by competition of 4.00. About 57.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 5.41. Novavax last dividend was issued on the 10th of May 2019. The entity had 1:20 split on the 10th of May 2019. Given the investment horizon of 90 days the next forecasted press release will be in about 10 days. Check out Novavax Basic Forecasting Models to cross-verify your projections.Novavax Related Hype Analysis
Having access to credible news sources related to Novavax's direct competition is more important than ever and may enhance your ability to predict Novavax's future price movements. Getting to know how Novavax's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Novavax may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| MRNA | Moderna | (0.42) | 10 per month | 2.64 | (0.01) | 6.04 | (4.08) | 18.90 | |
| INO | Inovio Pharmaceuticals | 1.18 | 9 per month | 5.64 | 0.05 | 12.74 | (8.51) | 30.56 | |
| BNTX | BioNTech SE | 2.44 | 10 per month | 0.00 | (0.17) | 2.21 | (2.17) | 9.89 | |
| VXRT | Vaxart Inc | (0.03) | 10 per month | 3.89 | 0.06 | 7.41 | (7.50) | 32.91 | |
| AZN | AstraZeneca PLC ADR | (0.43) | 8 per month | 1.15 | (0.01) | 2.28 | (1.81) | 7.48 |
Novavax Additional Predictive Modules
Most predictive techniques to examine Novavax price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Novavax using various technical indicators. When you analyze Novavax charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Novavax Predictive Indicators
The successful prediction of Novavax stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Novavax, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Novavax based on analysis of Novavax hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Novavax's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Novavax's related companies. | 2023 | 2024 (projected) | Dividend Yield | 0.007004 | 0.007918 | Price To Sales Ratio | 0.49 | 0.47 |
Story Coverage note for Novavax
The number of cover stories for Novavax depends on current market conditions and Novavax's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Novavax is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Novavax's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
View All Premium Stories
Novavax Short Properties
Novavax's future price predictability will typically decrease when Novavax's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Novavax often depends not only on the future outlook of the potential Novavax's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Novavax's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 100.8 M | |
| Cash And Short Term Investments | 578.9 M |
Check out Novavax Basic Forecasting Models to cross-verify your projections. For more information on how to buy Novavax Stock please use our How to Invest in Novavax guide.Note that the Novavax information on this page should be used as a complementary analysis to other Novavax's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Complementary Tools for Novavax Stock analysis
When running Novavax's price analysis, check to measure Novavax's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novavax is operating at the current time. Most of Novavax's value examination focuses on studying past and present price action to predict the probability of Novavax's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novavax's price. Additionally, you may evaluate how the addition of Novavax to your portfolios can decrease your overall portfolio volatility.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |
Is Novavax's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Novavax. If investors know Novavax will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Novavax listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.41) | Revenue Per Share 9.762 | Quarterly Revenue Growth (0.18) | Return On Assets (0.17) | Return On Equity (8.98) |
The market value of Novavax is measured differently than its book value, which is the value of Novavax that is recorded on the company's balance sheet. Investors also form their own opinion of Novavax's value that differs from its market value or its book value, called intrinsic value, which is Novavax's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Novavax's market value can be influenced by many factors that don't directly affect Novavax's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Novavax's value and its price as these two are different measures arrived at by different means. Investors typically determine if Novavax is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Novavax's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.